§ Mrs. MahonTo ask the Secretary of State for Health what action she is taking to help those suffering from arachnoiditis following treatment by Myodil used in spinal investigations to claim compensation from Glaxo; and if she will make a statement.
§ Mr. SackvilleThe Medicines Control Agency complied with a High Court order for discovery of documents relating to Myodil in 1991, but has had no further involvement. Myodil has not been marketed since 1987 when it was withdrawn by its manufacturer.